loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Artemisinin

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Artemisinin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 305Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fosun's Artemisinin Meds Boost Malaria Prevention in Africa
    Fosun's Artemisinin Meds Boost Malaria Prevention in Africa

    26 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fosun-pharmas-self-developed-artemisinin-medicines-inject-new-impetus-to-malaria-prevention-and-treatment-in-africa-302128373.html

    PR NEWSWIRE
    26 Apr 2024
    Share Share
    PULMOHEAL/ ARTIVEDA IS CLINICALLY ACTIVE AGAINST MILD AND MODERATE COVID-19.
    PULMOHEAL/ ARTIVEDA IS CLINICALLY ACTIVE AGAINST MILD AND MODERATE COVID-19.

    24 Aug 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/08/24/2285409/0/en/PULMOHEAL-ARTIVEDA-IS-CLINICALLY-ACTIVE-AGAINST-MILD-AND-MODERATE-COVID-19.html

    GLOBENEWSWIRE
    24 Aug 2021
    Share Share
    Manus Bio Awarded Additional Funding to Support its Artemisinin Program
    Manus Bio Awarded Additional Funding to Support its Artemisinin Program

    01 Apr 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/04/01/2203466/0/en/Manus-Bio-Awarded-Additional-Funding-to-Support-its-Artemisinin-Development-Program.html

    GLOBENEWSWIRE
    01 Apr 2021
    Share Share
    MGC Pharma expands ArtemiC™ phII clinical trial on COVID-19 patients
    MGC Pharma expands ArtemiC™ phII clinical trial on COVID-19 patients

    28 Sep 2020

    // Jessica Cummins PROACTIVE

    https://www.proactiveinvestors.com.au/companies/news/930059/mgc-pharmaceuticals-expands-artemic-phase-ii-clinical-trial-on-covid-19-patients-in-israel-and-india-930059.html

    Jessica Cummins PROACTIVE
    28 Sep 2020
    Share Share
    Mateon and Asili Research Alliance Enter Into Partnership for the Development
    Mateon and Asili Research Alliance Enter Into Partnership for the Development

    20 Jul 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/mateon-and-asili-research-alliance-enter-into-partnership-for-the-development-of-artemisinin-against-covid-19/

    BIOSPACE
    20 Jul 2020
    Share Share
    Mateon Therapeutics to fund observational studies of Artemisinin
    Mateon Therapeutics to fund observational studies of Artemisinin

    13 Jul 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/07/13/2061115/0/en/Mateon-Therapeutics-to-fund-observational-studies-of-Artemisinin-in-developing-countries.html

    GLOBENEWSWIRE
    13 Jul 2020
    Share Share